Chronic kidney disease, stage 4-5
Would you like to receive a message when new research about chronic kidney disease, stage 4-5 becomes available? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, one sentence appears above every publication explaining what was studied — and you'll be notified as soon as new research on Chronic kidney disease, stage 4-5 is available. View what Premium costs.
Publications and studies (2733)
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The role of gut microbiome in aging-associated diseases: where do we stand now and how technology will transform the future. (2026/12/31) ♡
- Molecular mechanism of Yishen Qingzhuo oral liquid in treating chronic renal failure via the Nrf2/HO-1-mediated ferroptosis pathway. (2026/12/01) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Yi-Shen-Hua-Shi granule added to supportive care reduces proteinuria in IgA nephropathy: a multicenter randomized controlled trial. (2026/12/01) ♡
- Illness perception and insomnia among patients with maintenance hemodialysis: a moderated mediation model of fear of progression and self-compassion. (2026/12/01) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Adherence to the Mediterranean diet and its effects on the onset and progression of diabetic nephropathy: a systematic review. (2026/12/01) ♡
- Integrative multi-omics analysis identifies VCAN and ESM1 as candidate cell-type-associated biomarkers of NET-related glomerular injury in diabetic kidney disease. (2026/12/01) ♡
- Pill burden and health-related quality of life across dialysis modalities: a multimodal assessment using KDQOL-36 and eQ-5D-5L. (2026/12/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Real-world effectiveness of central dialysis fluid delivery system (CDDS) in maintenance hemodialysis: a retrospective multicenter study. (2026/12/01) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Calciphylaxis in chronic kidney disease: a systematic review of pathomechanisms and risk factors for calcific uremic arteriolopathy. (2026/12/01) ♡
- Ginkgo biloba extract GBE50 alleviates vascular calcification through inhibiting the NF-κB pathway and the NLRP3 inflammasome. (2026/10/28) ♡
- Mechanistic elucidation of the therapeutic effects of Fushen Xiezhuo formula on chronic kidney disease. (2026/10/28) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Comment on "Comparison of ChatGPT-3.5, ChatGPT-4.0 and DeepSeek in generating dietary plans for patients with chronic kidney disease: A focus on nutritional accuracy and dietary inflammation". (2026/10/01) ♡
- Histone deacetylase 3‑mediated histone deacetylation combined with activating transcription factor 3 promotes renal fibrosis by inhibiting Klotho. (2026/10/01) ♡
- Niaoduqing particles ameliorated tubulointerstitial fibrosis by suppressing IκB/NF-κB signalling pathway via inhibiting host- and gut microbiota-mediated tryptophan co-metabolism. (2026/10/01) ♡
- Epidemiology of glomerular diseases in Northeastern Brazil from 2008-2024. (2026/10/01) ♡
- Qing'e Pill extract attenuates vascular calcification and improves renal dysfunction in chronic kidney disease mice by modulating calcium-phosphorus homeostasis and downregulating the expression of Runx2/OCN. (2026/09/15) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Discovery of anti-renal fibrosis quality markers from Piperis longi fructus: An integrated strategy of hollow fibre cell trapping method coupled with liquid chromatography-mass spectrometry and in vitro efficacy verification. (2026/09/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Beyond Glycemia in T1D: The Hidden Burden of Insulin Resistance and Cardiorenal Risk in Type 1 Diabetes-Part 1. (2026/09/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Current State of Cardiorenal Disease in People with Type 1 Diabetes. (2026/09/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Central Sleep Apnea in Renal and Endocrine Disease. (2026/09/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Identification of anti-fibrotic components of Bofutsushosan under conditions of age-associated obesity in mice. (2026/09/01) ♡
- Serum and Urine Metabolite Profiling Combined With Network Pharmacology to Predict the Renoprotective Mechanism of Huangkui Capsule Against Acute Kidney Injury. (2026/09/01) ♡
- Shen-Gu-Mai-Kang Formula alleviates CKD-associated vascular calcification by suppressing VSMC osteogenic transdifferentiation via the Sfrp2/β-catenin signaling. (2026/09/01) ♡
- Beraprost Attenuates Starvation-Induced Apoptosis and Protects Feline Endothelial Cells. (2026/09/01) ♡
- Wuling San ameliorates renal fibrosis through modulating S1PR2 activation and suppressing the RhoA/ROCK pathway in adenine-induced chronic kidney disease. (2026/08/10) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Traditional Chinese medicine as a therapeutic option for cerebral small vessel disease: treatment outcomes and potential mechanisms. (2026/08/10) ♡
- Network pharmacology and experimental verification reveal the mechanism of hederagenin in suppressing podocyte injury in focal segmental glomerular sclerosis. (2026/08/10) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Vitamin D status and supplementation in left ventricular remodeling in chronic kidney disease: A systematic review and meta-analysis. (2026/08/10) ♡
- Osteoporotic fracture, diagnostic activity, and treatment in patients with gout. (2026/08/10) ♡
- Correction to: Time-lapse HR-pQCT reliably assesses and monitors local bone turnover in patients with chronic kidney disease. (2026/08/10) ♡
- Exosomes in kidney disease: From Pathophysiology to Diagnostic and Therapeutic Tools. (2026/08/10) ♡
- Dynamic patterns of thyroid hormones and incident chronic kidney disease: evidence from 18 years of follow-up in the Tehran Thyroid Study. (2026/08/10) ♡
- Prognostic value of risk factors for ischaemic and major bleeding events in chronic coronary syndrome: a SWEDEHEART registry study. (2026/08/10) ♡
- Factors associated with selection of total hip arthroplasty versus hemiarthroplasty for femoral neck fracture in older adults: a nationwide analysis of 99,084 cases. (2026/08/10) ♡
- Difelikefalin Treatment in Chronic Kidney Disease-Associated Pruritus: Modelling Infection-Related Hospitalisation Cost Offsets Using Trial and Real-World Data Across Seven European Countries. (2026/08/10) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Gallstones and acute cholecystitis in CKD and dialysis: an underrecognized biliary burden in nephrology. (2026/08/10) ♡
- Prevalence, Incidence and Mortality of Chronic Kidney Disease in Type 1 and Type 2 Diabetes-A Nationwide Danish Register-Based Cohort Study. (2026/08/09) ♡
- Association between glomerular filtration rate and comprehensive geriatric assessment parameters in older adults. (2026/08/09) ♡
- Incident chronic kidney disease risk and the predictive value of the uric acid-to-HDL ratio in lean and non-lean MASLD: a prospective cohort and multi-omics study. (2026/08/09) ♡
- Type 2 Myocardial Infarction in Patients With Cardiorenal Vulnerability: Mechanisms, Diagnostic Challenges, and a Proposed Clinical Pathway. (2026/08/08) ♡
- Association of the combined triglyceride-glucose and frailty index with chronic kidney disease: evidence from two national cohort studies. (2026/08/08) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Sex and gender differences in the effects of immunosuppressive drugs in patients with kidney transplantation. (2026/08/08) ♡
- The AKI-CKD Continuum: Mechanisms and Therapeutic Interventions. (2026/08/08) ♡
- Association Between Dietary Magnesium Intake and All-Cause Mortality in Patients with Chronic Kidney Disease: Insights from NHANES 1999-2018. (2026/08/08) ♡
- Long-term Outcomes of Renal Function Following CTO PCI: Insights on Contrast Exposure. (2026/08/08) ♡
- Machine learning-assisted prediction of 5-year mortality in chronic kidney disease: the KoreaN cohort study for Outcome in patients With Chronic Kidney Disease (KNOW-CKD). (2026/08/07) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Contemporary medical therapy for heart failure with mildly reduced or preserved ejection fraction. (2026/08/07) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Are SGLT2 inhibitors really associated with increased urinary tract infection risk? A trial-level meta-analysis across type 2 diabetes, heart failure, and chronic kidney disease. (2026/08/07) ♡
- Impact of race on comorbidity burden and clinical outcomes among Southeast Asians with lupus nephritis: a single-center retrospective study. (2026/08/07) ♡
- Metabolic Dysfunction-Associated Steatotic Liver Disease, Cardiovascular, and Kidney Disease: Triple Challenges. (2026/08/07) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.